Ipca acquires further 6.53% of equity share of Trophic Wellness
Ipca Laboratories now holds 58.88% of the paid-up equity share capital of the company.
Ipca Laboratories now holds 58.88% of the paid-up equity share capital of the company.
The company has reported total income of Rs. 1607.85 crores during the period ended June 30, 2022.
The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.
For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore
Total income grew in the quarter
With the acquisition of these further shares, TWPL has now become company's subsidiary.
The company has posted net profit of Rs.1140.01 crores during FY 2020-21
Indian Pharmacopoeia Commission hosts scientific conclave to brainstorm on strengthening pharmaceutical quality and compliance
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes
Subscribe To Our Newsletter & Stay Updated